Literature DB >> 16528017

Fibroblasts of recipient origin contribute to bronchiolitis obliterans in human lung transplants.

Verena Bröcker1, Florian Länger, Tariq G Fellous, Michael Mengel, Mairi Brittan, Martin Bredt, Simone Milde, Tobias Welte, Matthias Eder, Axel Haverich, Malcolm R Alison, Hans Kreipe, Ulrich Lehmann.   

Abstract

RATIONALE: The participation of circulating precursor cells in the development of experimental pulmonary fibrosing lesions in mice has been recently demonstrated.
OBJECTIVES: This study analyzes whether circulating, bone marrow-derived, fibroblastic precursor cells contribute to the development of fibrosing lesions in human lungs, especially bronchiolitis obliterans.
METHODS: The occurrence of in situ microchimerism in bronchiolitis obliterans lesions of human lung allografts (n = 12) as well as of autologous lung tissue from patients post-bone marrow transplantation (n = 2) was analyzed using laser-assisted microdissection after immunohistochemical labeling of leukocytes followed by short tandem repeat-polymerase chain reaction-based genotyping. Combined immunofluorescence and fluorescence in situ hybridization for sex chromosomes was performed for independent confirmation in cases with appropriate sex mismatch (n = 2).
MEASUREMENTS AND MAIN RESULTS: The bronchiolitis obliterans lesions of all 12 lung transplant patients contained considerable numbers of recipient-derived fibroblasts (mean, 32%). The fibrosing pulmonary lesions of the two bone marrow-transplanted patients also displayed clear in situ microchimerism. The in situ detection methodology confirmed these results, although to a lower degree (6-16%).
CONCLUSIONS: These data clearly demonstrate the involvement of circulating fibroblastic precursor cells in the development of human fibrosing lung lesions and provide evidence that these cells are most probably bone marrow derived. These results may open new venues regarding the prevention of fibrosis in lung transplants and potentially in other organs.

Entities:  

Mesh:

Year:  2006        PMID: 16528017     DOI: 10.1164/rccm.200509-1381OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  20 in total

Review 1.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Jay K Kolls; Luis A Ortiz; Angela Panoskaltsis-Mortari; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

2.  Circulating progenitor cells in chronic lung disease.

Authors:  Borna Mehrad; Michael P Keane; Brigitte N Gomperts; Robert M Strieter
Journal:  Expert Rev Respir Med       Date:  2007-08       Impact factor: 3.772

3.  Obliterative airway remodeling: molecular evidence for shared pathways in transplanted and native lungs.

Authors:  Danny Jonigk; Marlene Merk; Kais Hussein; Lavinia Maegel; Katharina Theophile; Michaela Muth; Ulrich Lehmann; Clemens L Bockmeyer; Michael Mengel; Jens Gottlieb; Tobias Welte; Axel Haverich; Heiko Golpon; Hans Kreipe; Florian Laenger
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

4.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Ivan Bertoncello; Zea Borok; Carla Kim; Angela Panoskaltsis-Mortari; Susan Reynolds; Mauricio Rojas; Barry Stripp; David Warburton; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2011-06

Review 5.  [Fibrotic remodeling of the lung following lung and stem-cell transplantation].

Authors:  Christopher Werlein; Max Ackermann; Thia Leandra Hoffmann; Florian Laenger; Danny Jonigk
Journal:  Pathologe       Date:  2021-01-08       Impact factor: 1.011

Review 6.  Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.

Authors:  Vibha N Lama; John A Belperio; Jason D Christie; Souheil El-Chemaly; Michael C Fishbein; Andrew E Gelman; Wayne W Hancock; Shaf Keshavjee; Daniel Kreisel; Victor E Laubach; Mark R Looney; John F McDyer; Thalachallour Mohanakumar; Rebecca A Shilling; Angela Panoskaltsis-Mortari; David S Wilkes; Jerry P Eu; Mark R Nicolls
Journal:  JCI Insight       Date:  2017-05-04

Review 7.  Chronic lung allograft dysfunction phenotypes and treatment.

Authors:  Stijn E Verleden; Robin Vos; Bart M Vanaudenaerde; Geert M Verleden
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

8.  Regression of allograft airway fibrosis: the role of MMP-dependent tissue remodeling in obliterative bronchiolitis after lung transplantation.

Authors:  Masaaki Sato; David M Hwang; Zehong Guan; Jonathan C Yeung; Masaki Anraku; Dirk Wagnetz; Shin Hirayama; Thomas K Waddell; Mingyao Liu; Shaf Keshavjee
Journal:  Am J Pathol       Date:  2011-07-16       Impact factor: 4.307

9.  Treadmill running exercise results in the presence of numerous myofibroblasts in mouse patellar tendons.

Authors:  Michal Szczodry; Jianying Zhang; Chanteak Lim; Hongxia L Davitt; Torin Yeager; Freddie H Fu; James H-C Wang
Journal:  J Orthop Res       Date:  2009-10       Impact factor: 3.494

10.  Fibrocytes are associated with vascular and parenchymal remodelling in patients with obliterative bronchiolitis.

Authors:  Annika Andersson-Sjöland; Jonas S Erjefält; Leif Bjermer; Leif Eriksson; Gunilla Westergren-Thorsson
Journal:  Respir Res       Date:  2009-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.